TALLAC THERAPEUTICS
Live / Registered — Registered (as of 09 Jan 2024)
What this means for you
Registered since 09 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90016459
- Registration number
- 7270000
- Mark type
- Stylized text
- Filed
- 23 Jun 2020
- Published for opposition
- 27 Apr 2021
- Registered
- 09 Jan 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals in the field of immune cell activation with toll-like receptor agonist antibody-conjugates (TRAAC), namely, pharmaceuticals for the treatment and prevention of immune system related diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, and cancer
Owner
- TALLAC THERAPEUTICS, INC., SAN FRANCISCO, CA, US
- TALLAC THERAPEUTICS, INC., SAN FRANCISCO, CA, US
- TALLAC THERAPEUTICS, INC., SAN FRANCISCO, CA, US
Prosecution history
- 09 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 07 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Nov 2023 — USE AMENDMENT FILED
- 14 Nov 2023 — SOU EXTENSION 5 GRANTED
- 09 Nov 2023 — SOU EXTENSION 5 FILED
- 09 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 09 Nov 2023 — TEAS STATEMENT OF USE RECEIVED
- 20 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2023 — SOU EXTENSION 4 GRANTED
- 18 Jun 2023 — SOU EXTENSION 4 FILED
- 18 Jun 2023 — SOU TEAS EXTENSION RECEIVED